A Phase I Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Skin Cancer
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Tozuleristide (Primary)
- Indications Basal cell cancer; Malignant melanoma; Skin cancer; Squamous cell cancer
- Focus Adverse reactions; First in man
- Sponsors Blaze Bioscience
- 27 Oct 2015 According to a Blaze Bioscience media release, data from this study will be presented at the 2015 2nd Global Advances and Controversies in Skin Cancer (GAC-SC) Conference.
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 27 May 2015 According to a Blaze Bioscience media release, data from this study will be presented at the American Society of Surgical Oncology (ASCO) 2015 Annual Meeting.